Cargando…

The current status of renal cell carcinoma and prostate carcinoma grading

Detalles Bibliográficos
Autores principales:	Delahunt, Brett, Egevad, Lars, Yaxley, John, Samaratunga, Hemamali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2018
Materias:	Editorial in this Issue
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442168/ https://www.ncbi.nlm.nih.gov/pubmed/30516924 http://dx.doi.org/10.1590/S1677-5538.IBJU.2018.06.01

Ejemplares similares

Intraductal carcinoma of the prostate: a critical re-appraisal
por: Varma, Murali, et al.
Publicado: (2019)

Ductal and acinar components of mixed prostatic adenocarcinoma frequently have a common clonal origin
por: Lindh, Claes, et al.
Publicado: (2022)

The ISUP system of staging, grading and classification of renal cell neoplasia
por: Samaratunga, Hemamali, et al.
Publicado: (2014)

Detection of perineural invasion in prostate needle biopsies with deep neural networks
por: Kartasalo, Kimmo, et al.
Publicado: (2022)

Oncological and urinary outcomes following low‐dose‐rate brachytherapy with a median follow‐up of 11.8 years
por: Yaxley, William John, et al.
Publicado: (2022)

Prostate cancer grading, time to go back to the future
por: Egevad, Lars, et al.
Publicado: (2020)

Interobserver reproducibility of perineural invasion of prostatic adenocarcinoma in needle biopsies
por: Egevad, Lars, et al.
Publicado: (2021)

Perithyroidal Salivary Gland Acinic Cell Carcinoma: Morphological and Molecular Attributes of a Unique Lesion
por: Juhlin, C. Christofer, et al.
Publicado: (2020)

Prognostic value of perineural invasion in prostate needle biopsies: a population-based study of patients treated by radical prostatectomy
por: Ström, Peter, et al.
Publicado: (2020)

Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy
por: Roberts, Matthew J., et al.
Publicado: (2022)

The International Society of Urological Pathology Education web—a web-based system for training and testing of pathologists
por: Egevad, Lars, et al.
Publicado: (2019)

Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading
por: Egevad, Lars, et al.
Publicado: (2020)

Estimating diagnostic uncertainty in artificial intelligence assisted pathology using conformal prediction
por: Olsson, Henrik, et al.
Publicado: (2022)

Our Current Understanding of the Heterogeneity in Prostate Cancer and Renal Cell Carcinoma
por: Zhu, Sha, et al.
Publicado: (2023)

Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge
por: Bulten, Wouter, et al.
Publicado: (2022)

Prostate-based biofluids for the detection of prostate cancer: A comparative study of the diagnostic performance of cell-sourced RNA biomarkers
por: Roberts, Matthew J., et al.
Publicado: (2016)

The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
por: van Leenders, Geert J.L.H., et al.
Publicado: (2020)

Two-dimensional correlated spectroscopy distinguishes clear cell renal cell carcinoma from other kidney neoplasms and non-cancer kidney
por: Del Vecchio, Sharon J., et al.
Publicado: (2022)

Low-Grade Serous Carcinoma of the Ovary: The Current Status
por: Babaier, Abdulaziz, et al.
Publicado: (2022)

Intraductal Carcinoma of the Prostate: To Grade or Not to Grade
por: Surintrspanont, Jerasit, et al.
Publicado: (2023)

Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma
por: Frödin, Magnus, et al.
Publicado: (2017)

New Insights into Diagnosis and Treatment of Renal Cell Carcinoma, Bladder Cancer, and Prostate Cancer
por: Chlosta, Piotr L., et al.
Publicado: (2017)

Retreatment in locally recurrent nasopharyngeal carcinoma: Current status and perspectives
por: Poh, Sharon Shuxian, et al.
Publicado: (2021)

Metastatic renal cell carcinoma to the prostate and seminal vesicle
por: Wiesen, Brett, et al.
Publicado: (2020)

Current Status of Targeted Therapy for Advanced Renal Cell Carcinoma
por: Cho, In-Chang, et al.
Publicado: (2012)

The current status of immunobased therapies for metastatic renal-cell carcinoma
por: Sathianathen, Niranjan J, et al.
Publicado: (2017)

The Labyrinth of Renal Cell Carcinoma
por: Manini, Claudia, et al.
Publicado: (2020)

Editorial Comment to Case of renal mucinous tubular and spindle cell carcinoma with high nuclear grade
por: Inamoto, Teruo, et al.
Publicado: (2019)

Current status of the focused series “Urothelial Carcinoma”
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

Perivascular Neuropilin‐1 expression is an independent marker of improved survival in renal cell carcinoma
por: Morin, Eric, et al.
Publicado: (2020)

Lichen sclerosus presenting as an isolated bulbar urethral stricture
por: Attia, Arsany, et al.
Publicado: (2021)

Current Status of Immunotherapy for Localized and Locally Advanced Renal Cell Carcinoma
por: Ghali, Fady, et al.
Publicado: (2019)

Current Status of Tivozanib in the Treatment of Patients With Advanced Renal Cell Carcinoma
por: Sakellakis, Minas, et al.
Publicado: (2023)

The multiparametric prostate resonance imaging with the prostate imaging-reporting and data system (PI-RADS): the state of art of prostate cancer diagnosis
Publicado: (2019)

WHO/ISUP grading of clear cell renal cell carcinoma and papillary renal cell carcinoma; validation of grading on the digital pathology platform and perspectives on reproducibility of grade
por: Browning, Lisa, et al.
Publicado: (2021)

The current status of scientific research and hormonal treatments for carcinoma of the prostate.
por: Waxman, J., et al.
Publicado: (1991)

Are we ready to include invasive cribriform and intraductal carcinoma into the prostate cancer grade grouping system?
por: Xiao, Guang-Qian, et al.
Publicado: (2020)

Current status of antigen-specific T-cell immunotherapy for advanced renal-cell carcinoma
por: Xu, Yuexin, et al.
Publicado: (2021)

Focal Therapy for Prostatic Carcinoma
por: Barret, Eric
Publicado: (2012)

Immune checkpoint inhibitors in renal cell carcinoma
por: Ross, Kirsty, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m42n1fikmhqj4s5ts0o3tnd2sp